Literature DB >> 20304923

The signal peptide of the IgE receptor alpha-chain prevents surface expression of an immunoreceptor tyrosine-based activation motif-free receptor pool.

Barbara Platzer1, Edda Fiebiger.   

Abstract

The high affinity receptor for IgE, Fc epsilon receptor I (FcepsilonRI), is an activating immune receptor and key regulator of allergy. Antigen-mediated cross-linking of IgE-loaded FcepsilonRI alpha-chains induces cell activation via immunoreceptor tyrosine-based activation motifs in associated signaling subunits, such as FcepsilonRI gamma-chains. Here we show that the human FcepsilonRI alpha-chain can efficiently reach the cell surface by itself as an IgE-binding receptor in the absence of associated signaling subunits when the endogenous signal peptide is swapped for that of murine major histocompatibility complex class-I H2-K(b). This single-chain isoform of FcepsilonRI exited the endoplasmic reticulum (ER), trafficked to the Golgi and, subsequently, trafficked to the cell surface. Mutational analysis showed that the signal peptide regulates surface expression in concert with other described ER retention signals of FcepsilonRI-alpha. Once the FcepsilonRI alpha-chain reached the cell surface by itself, it formed a ligand-binding receptor that stabilized upon IgE contact. Independently of the FcepsilonRI gamma-chain, this single-chain FcepsilonRI was internalized after receptor cross-linking and trafficked into a LAMP-1-positive lysosomal compartment like multimeric FcepsilonRI. These data suggest that the single-chain isoform is capable of shuttling IgE-antigen complexes into antigen loading compartments, which plays an important physiologic role in the initiation of immune responses toward allergens. We propose that, in addition to cytosolic and transmembrane ER retention signals, the FcepsilonRI alpha-chain signal peptide contains a negative regulatory signal that prevents expression of an immunoreceptor tyrosine-based activation motif-free IgE receptor pool, which would fail to induce cell activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304923      PMCID: PMC2865261          DOI: 10.1074/jbc.M110.104281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Targeting proteins to membranes: structure of the signal recognition particle.

Authors:  Pascal F Egea; Robert M Stroud; Peter Walter
Journal:  Curr Opin Struct Biol       Date:  2005-04       Impact factor: 6.809

Review 2.  ERAD: the long road to destruction.

Authors:  Birgit Meusser; Christian Hirsch; Ernst Jarosch; Thomas Sommer
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

Review 3.  New developments in FcepsilonRI regulation, function and inhibition.

Authors:  Stefan Kraft; Jean-Pierre Kinet
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

4.  Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.

Authors:  D Dombrowicz; V Flamand; I Miyajima; J V Ravetch; S J Galli; J P Kinet
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Export of the high affinity IgE receptor from the endoplasmic reticulum depends on a glycosylation-mediated quality control mechanism.

Authors:  B Albrecht; M Woisetschläger; M W Robertson
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

Review 6.  Type I signal peptidase: an overview.

Authors:  Renu Tuteja
Journal:  Arch Biochem Biophys       Date:  2005-09-15       Impact factor: 4.013

7.  Endosomal trafficking of the ligated FcvarepsilonRI receptor.

Authors:  Gul'nar V Fattakhova; Madhan Masilamani; Sriram Narayanan; Francisco Borrego; Alasdair M Gilfillan; Dean D Metcalfe; John E Coligan
Journal:  Mol Immunol       Date:  2008-10-22       Impact factor: 4.407

Review 8.  IgE in allergy and asthma today.

Authors:  Hannah J Gould; Brian J Sutton
Journal:  Nat Rev Immunol       Date:  2008-03       Impact factor: 53.106

9.  How MHC class II molecules reach the endocytic pathway.

Authors:  P Bénaroch; M Yilla; G Raposo; K Ito; K Miwa; H J Geuze; H L Ploegh
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

10.  Cotranslational endoplasmic reticulum assembly of FcepsilonRI controls the formation of functional IgE-binding receptors.

Authors:  Edda Fiebiger; Domenico Tortorella; Marie-Helene Jouvin; Jean-Pierre Kinet; Hidde L Ploegh
Journal:  J Exp Med       Date:  2005-01-10       Impact factor: 14.307

View more
  11 in total

Review 1.  Soluble IgE receptors--elements of the IgE network.

Authors:  Barbara Platzer; Floortje Ruiter; John van der Mee; Edda Fiebiger
Journal:  Immunol Lett       Date:  2011-09-06       Impact factor: 3.685

2.  Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors.

Authors:  Emma Comas-Casellas; Águeda Martínez-Barriocanal; Francesc Miró; Aroa Ejarque-Ortiz; Simo Schwartz; Margarita Martín; Joan Sayós
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

Review 3.  Functions of dendritic-cell-bound IgE in allergy.

Authors:  Barbara Platzer; Madeleine Stout; Edda Fiebiger
Journal:  Mol Immunol       Date:  2015-06-04       Impact factor: 4.407

4.  Development and validation of a standardized ELISA for the detection of soluble Fc-epsilon-RI in human serum.

Authors:  Willem Lexmond; John van der Mee; Floortje Ruiter; Barbara Platzer; Georg Stary; Elizabeth H Yen; Eleonora Dehlink; Samuel Nurko; Edda Fiebiger
Journal:  J Immunol Methods       Date:  2011-08-28       Impact factor: 2.303

5.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

6.  Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.

Authors:  Shiteng Duan; Britni M Arlian; Corwin M Nycholat; Yadong Wei; Hiroaki Tateno; Scott A Smith; Matthew S Macauley; Zhou Zhu; Bruce S Bochner; James C Paulson
Journal:  J Immunol       Date:  2021-04-28       Impact factor: 5.422

7.  A soluble form of the high affinity IgE receptor, Fc-epsilon-RI, circulates in human serum.

Authors:  Eleonora Dehlink; Barbara Platzer; Alexandra H Baker; Jessica Larosa; Michael Pardo; Peter Dwyer; Elizabeth H Yen; Zsolt Szépfalusi; Samuel Nurko; Edda Fiebiger
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

Review 8.  Immunoglobulin E receptor signaling and asthma.

Authors:  Lawren C Wu
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

9.  A targeted RNAi screen identifies factors affecting diverse stages of receptor-mediated transcytosis.

Authors:  Bradlee Nelms; Natasha Furtado Dalomba; Wayne Lencer
Journal:  J Cell Biol       Date:  2017-01-09       Impact factor: 10.539

10.  Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency.

Authors:  Louise Saul; Debra H Josephs; Keith Cutler; Andrew Bradwell; Panagiotis Karagiannis; Chris Selkirk; Hannah J Gould; Paul Jones; James F Spicer; Sophia N Karagiannis
Journal:  MAbs       Date:  2014-01-14       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.